Latest News

The listing below shows our latest News Items and is updated regularly.  If you wish to post a news item please select the 'Post News' button on the right.  The displayed news feed starts on 1st August 2016.  Older items can be found here.

To 'Post Your News' use the button at the top right.



Blue Earth Diagnostics celebrates five year anniversary

Oxford, UK – March 6, 2019 – Blue Earth Diagnostics, a leading molecular imaging diagnostics company, recently celebrated the company’s five year anniversary. During this time, Blue Earth Diagnostics has delivered five years of innovation and continued growth with a proven track record and depth of expertise in the rapid development and global commercialization of radiopharmaceuticals for cancer management. Blue Earth Diagnostics employs over 100 people in Europe and in the USA.

Read the rest of entry »

OBN Monthly Newsletter

Please take a look at the next edition of our OBN Monthly Newsletter. We hope that you find it interesting and useful.

Read the rest of entry »

Gentle and Rapid Cell Detachment

Detachin™ Cell Detachment Solution from AMSBIO is a high-performance alternative to Trypsin/EDTA for detaching adherent cells from in vitro growth vessels. Detachin™ provides rapid, gentle, and effective detachment of a wide variety of adherent cells, including primary cells, from all commercially available tissue culture plasticware.

Read the rest of entry »

Minerva Business Angels partners with Aston University and University of Birmingham Enterprise to launch new angel investor network for Birmingham

27 February 2019: Aston University and University of Birmingham Enterprise have teamed up with Minerva, one of the UK’s largest traditional angel investor networks, to expand the funding opportunities available to start-up businesses in the West Midlands by launching a network of ‘business angels with insight’ for Birmingham.

Read the rest of entry »

Absolute Antibody Develops Custom Purification Systems to Enable High-Throughput Recombinant Antibody Production

Oxford, UK, February 20, 2019. Absolute Antibody Ltd., an industry-leading manufacturer of recombinant antibodies, has developed custom protein purification systems to significantly increase its antibody production throughput.

Read the rest of entry »

OBN Launches New Purchasing Platform to Provide E-Commerce Solution for its Members

Abingdon, UK; 19th February 2019 - OBN, the Membership organisation supporting the UK’s innovative life sciences companies, is pleased to announce today the launch of its new online Purchasing Platform.  The aim of the new Purchasing Platform, which can be accessed by OBN’s Full Members, Sponsors and Supporters, is to enable users to have a better overview and control of spend and save time and money.

Read the rest of entry »

Innovate UK have released their Smart Grants competition which has £20 million available to all industry sectors

Good news! It’s finally here and has been rebranded as Smart Grants. If you’ve been working within the R&D funding world for as long as we have, you will know that a couple of years ago, ‘Smart’ was the name of the Open, so the name may induce a slight feeling of déjà vu!

Read the rest of entry »

CRISPR/Cas9 Knockout Cell Lines and Lysates

AMSBIO has established a comprehensive portfolio of knock-out cell lines and lysates generated with CRISPR/Cas9 technology.

Using CRISPR/Cas9 gene editing technology for the generation of knock-out cell lines and cell lysates ensures the development of useful tools to validate antibody specificity and elucidate gene function. Knock-out cell lines and cell lysates are widely agreed to be the best negative controls to quickly and confidently prove an antibody’s specificity for a target of interest and ensure reproducibility.

Read the rest of entry »

PRESS RELEASE First production and administration of Axumin® (fluciclovine (18F)) in Italy.

Oxford, UK – February 12, 2019 – Blue Earth Diagnostics, a leading molecular imaging diagnostics company, today announced that the first commercial production of Axumin® (fluciclovine (18F)) in Italy occurred recently, with the first Italian patients being dosed.

Read the rest of entry »

Super-Fast-Acting Prandial Insulin Product Receives £0.5M Innovate UK Boost

Arecor Ltd, the specialty pharmaceutical company leveraging its innovative and proprietary formulation technology to develop superior treatments for a range of disease areas, including diabetes, is pleased to announce that the Company has been awarded a £0.5 million grant from Innovate UK, the UK’s innovation agency, to advance the Company's proprietary super-fast-acting prandial insulin product, AT270.

Read the rest of entry »

Search Posts

News Policy

OBN aims to provide sector NEWS that is relevant to our Membership. We filter information from a variety of sources, publish items ourselves and will publish items of News from our Members. Press releases about OBN can be found here.